Literature DB >> 29156363

Quality of life is associated with chronic inflammation in depression: A cross-sectional study.

M Faugere1, J-A Micoulaud-Franchi2, C Faget-Agius3, C Lançon3, M Cermolacce4, R Richieri5.   

Abstract

BACKGROUND: Inflammation may play a crucial role in the pathophysiology of depression. However, the association between chronic inflammation and health outcomes in depression remains unclear, particularly for patient-reported outcomes.
METHODS: The aim of this study was to investigate the relationship between quality of life (QoL) (physical and mental health, assessed by the SF-36) and chronic inflammation assessed using C-reactive protein (CRP) in patients with current major depressive disorder.
RESULTS: One hundred eighty-one patients with depression were enrolled in this study. After adjusting for key socio-demographic, clinical and biological confounding factors, patients with high levels of CRP (> 3.0mg/L) had worse physical health than those with normal CRP levels (OR = 0.95, 95% CI = 0.92-0.99). Significant associations were found between a higher rate of metabolic syndrome (OR = 0.10, 95% CI = 0.02-0.41) and high CRP levels. LIMITATIONS: The cut-off point for high cardiovascular risk was used to define the two groups: normal CRP level and high CRP level. CRP was the sole marker of inflammation in this study and was collected at only one time point. The design of this study is cross-sectional and there are no conclusions about the directionality of the association between QoL and inflammation in depression. QoL was assessed only by SF-36 scores.
CONCLUSION: This study found an association between SF-36 physical health score and CRP in patients with depression, thereby showing the need to consider physical well-being in depression. This paves the way for interventions to act both on inflammation and QoL in patients with depression.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Depression; Inflammation; Quality of life

Mesh:

Substances:

Year:  2017        PMID: 29156363     DOI: 10.1016/j.jad.2017.11.061

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

1.  Exploring the associations between systemic inflammation, obesity and healthy days: a health related quality of life (HRQOL) analysis of NHANES 2005-2008.

Authors:  Jeffrey Wilkins; Palash Ghosh; Juan Vivar; Bibhas Chakraborty; Sujoy Ghosh
Journal:  BMC Obes       Date:  2018-08-06

2.  Inflammation and quality of life in later life: findings from the health, well-being and aging study (SABE).

Authors:  Manuela de Almeida Roediger; Maria de Fátima Nunes Marucci; Etienne Larissa Duim; Jair Lício Ferreira Santos; Yeda Aparecida de Oliveira Duarte; Cesar de Oliveira
Journal:  Health Qual Life Outcomes       Date:  2019-02-06       Impact factor: 3.186

3.  Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression.

Authors:  Christiane Mühle; Claudia Johanna Wagner; Katharina Färber; Tanja Richter-Schmidinger; Erich Gulbins; Bernd Lenz; Johannes Kornhuber
Journal:  J Clin Med       Date:  2019-06-13       Impact factor: 4.241

4.  Associations among inflammation, mental health, and quality of life in adults with metabolic syndrome.

Authors:  Ji-Ryang Kim; Ha-Na Kim; Sang-Wook Song
Journal:  Diabetol Metab Syndr       Date:  2018-08-31       Impact factor: 3.320

5.  Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.

Authors:  Shirin Kalyan; Azita Goshtesabi; Sameh Sarray; Angela Joannou; Wassim Y Almawi
Journal:  BMJ Open       Date:  2018-10-27       Impact factor: 2.692

6.  The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review.

Authors:  Malini Pires; Barry Wright; Paul M Kaye; Virgínia da Conceição; Rachel C Churchill
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

7.  Clinical phenotypes of depressed patients with evidence of inflammation and somatic symptoms.

Authors:  Éimear M Foley; Joel T Parkinson; Nils Kappelmann; Golam M Khandaker
Journal:  Compr Psychoneuroendocrinol       Date:  2021-08-05

8.  Calorie restriction and synbiotics effect on quality of life and edema reduction in breast cancer-related lymphedema, a clinical trial.

Authors:  Saeideh Vafa; Mitra Zarrati; Marjan Malakootinejad; Ali Saneei Totmaj; Farid Zayeri; Masoud Salehi; Vahid Sanati; Shahpar Haghighat
Journal:  Breast       Date:  2020-08-27       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.